GlassScriptPhysician profile
Kelly D Visentine
NPI 1396979944
$3,374.76
in general payments reported to CMS, 2019-2025
16 companies · $916 in 2025
The $916 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $628 · 2020: $122 · 2021: $137 · 2022: $238 · 2023: $479 · 2024: $855 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,249.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $644.50 | 2019-2025 | Total30, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $630.90 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $396.75 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $343.52 | 2022-2025 | Infuse |
| Dompe US, INC. | $219.35 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $212.60 | 2024-2025 | |
| Optos, INC. | $208.85 | 2025 | |
| Sun Pharmaceutical Industries INC. | $204.53 | 2020-2025 | Cequa |
| Coopervision INC. | $138.06 | 2021-2024 | Misight Contact Lens, Myday Contact Lens |
| Shire North American Group INC | $122.08 | 2019 | |
| Allergan, INC. | $93.84 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $49.81 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $47.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.43 | 2023 | |
| Abbvie INC. | $21.65 | 2023 | Vuity, Lumigan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $14.97 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Visentine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.